The Journal of Urology
Volume 180, Issue 2 , Pages 444-450 , August 2008

Management of Ureteral Obstruction Due to Advanced Malignancy: Optimizing Therapeutic and Palliative Outcomes

  • Erik Kouba
    • ,
  • Eric M. Wallen
    • ,
  • Raj S. Pruthi

      Affiliations

    • Corresponding Author InformationCorrespondence and requests for reprints: Division of Urologic Surgery, University of North Carolina at Chapel Hill, 2140 Bioinformatics Building, CB No. 7235, Chapel Hill, North Carolina 27599 (telephone: 919-966-2574; FAX: 919-966-0098).

Received 18 November 2007

References 

  1. Russo P. Ureteral obstruction and stents: still a difficult problem for patients and urologists alike. J Urol. 2005;174:2088
  2. Shekarriz B, Shekarriz H, Upadhyay J, Banerjee M, Becker H, Pontes JE, et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer. 1999;85:998
  3. Romero FR, Broglio M, Pires SR, Roca RF, Guibu IA, Perez MD. Indications for percutaneous nephrostomy in patients with obstructive uropathy due to malignant urogenital neoplasias. Int Braz J Urol. 2005;31:117
  4. Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol. 2005;174:2125
  5. Desgrandchamps F, Leroux S, Ravery V, Bochereau G, Menut P, Meria P, et al. Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life. J Endourol. 2007;21:173
  6. Roza C, Laird JM. Pressor responses to distension of the ureter in anaesthetised rats: characterisation of a model of acute visceral pain. Neurosci Lett. 1995;198:9
  7. Olivar T, Laird JM. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain. 1999;79:67
  8. Laird JM, Roza C, Cervero F. Spinal dorsal horn neurons responding to noxious distension of the ureter in anesthetized rats. J Neurophysiol. 1996;76:3239
  9. Baik EJ, Jeong Y, Nam TS, Kim WK, Paik KS. Mechanism of transmission and modulation of renal pain in cats: effect of nucleus raphe magnus stimulation on renal pain. Yonsei Med J. 1995;36:348
  10. Shafik A. Demonstration of a “renogastric reflex” after rapid distension of renal pelvis and ureter in nonanesthetized patients. Urology. 1999;53:38
  11. El-Nahas AR, El-Assmy AM, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA. Self-retaining ureteral stents: analysis of factors responsible for patients' discomfort. J Endourol. 2006;20:33
  12. Heid F, Jage J. The treatment of pain in urology. BJU Int. 2002;90:481
  13. Laird JM, Roza C, Cervero F. Effects of artificial calculosis on rat ureter motility: peripheral contribution to the pain of ureteric colic. Am J Physiol. 1997;272:R1409
  14. Jerde TJ, Calamon-Dixon JL, Bjorling DE, Nakada SY. Celecoxib inhibits ureteral contractility and prostanoid release. Urology. 2005;65:185
  15. Pruthi RS, Kouba E, Carson CC, Wallen EM. Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?. Urology. 2006;68:917
  16. Norregaard R, Jensen BL, Topcu SO, Nielsen SS, Walter S, Djurhuus JC, et al. Cyclooxygenase type 2 is increased in obstructed rat and human ureter and contributes to pelvic pressure increase after obstruction. Kidney Int. 2006;70:872
  17. Fujinaka H, Miyazaki Y, Matsusaka T, Yoshida H, Fogo AB, Inagami T, et al. Salutary role for angiotensin in partial urinary tract obstruction. Kidney Int. 2000;58:2018
  18. Santis WF, Peters CA, Yalla SV, Sullivan MP. Ureteral function is modulated by a local renin-angiotensin system. J Urol. 2003;170:259
  19. Walsh TD, West TS. Malignant ureteric obstruction relieved by dexamethasone. Postgrad Med J. 1984;60:437
  20. Hamdy FC, Williams JL. Use of dexamethasone for ureteric obstruction in advanced prostate cancer: percutaneous nephrostomies can be avoided. Br J Urol. 1995;75:782
  21. Scheel PJ, Piccini J, Rahman MH, Lawler L, Jarrett T. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178:140
  22. Sahin A, Erdemli I, Bakkaloglu M, Ergen A, Basar I, Remzi D. The effect of nifedipine and verapamil on rhythmic contractions of human isolated ureter. Arch Int Physiol Biochim Biophys. 1993;101:245
  23. Achar E, Achar RA, Paiva TB, Campos AH, Schor N. Amitriptyline eliminates calculi through urinary tract smooth muscle relaxation. Kidney Int. 2003;64:1356
  24. Du S, Araki I, Mikami Y, Zakoji H, Beppu M, Yoshiyama M, et al. Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology. 2007;69:590
  25. Wanajo I, Tomiyama Y, Tadachi M, Kobayashi M, Yamazaki Y, Kojima M, et al. The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics. Urol Res. 2005;33:409
  26. Castroman PJ, Ness TJ. Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the spinal neuronal responses to distension of the rat urinary bladder. Anesthesiology. 2002;96:1410
  27. Radecka E, Magnusson M, Magnusson A. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Acta Radiol. 2006;47:328
  28. Wong LM, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction: outcomes after intervention (Have things changed?). J Urol. 2007;178:178
  29. Chapman ME, Reid JH. Use of percutaneous nephrostomy in malignant ureteric obstruction. Br J Radiol. 1991;64:318
  30. Markowitz DM, Wong KT, Laffey KJ, Bixon R, Nagler HM, Martin EC. Maintaining quality of life after palliative diversion for malignant ureteral obstruction. Urol Radiol. 1989;11:129
  31. Eyre RC, Benotti PN, Bothe A, Cady B, Steele G. Management of the urinary tract involved by recurrent cancer. Arch Surg. 1987;122:493
  32. Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?. Urology. 2004;64:895
  33. Wilson JR, Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl. 2005;87:21
  34. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003;169:1065
  35. Joshi HB, Stainthorpe A, Keeley FX, MacDonagh R, Timoney AG. Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol. 2001;15:151
  36. Hruby GW, Ames CD, Yan Y, Monga M, Landman J. Correlation of ureteric length with anthropometric variables of surface body habitus. BJU Int. 2007;99:1119
  37. Jeon SS, Choi YS, Hong JH. Determination of ideal stent length for endourologic surgery. J Endourol. 2007;21:906
  38. Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol. 2006;16:77
  39. Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS, et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol. 2005;174:2303
  40. Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol. 2006;20:300
  41. Emmert C, Rassler J, Kohler U. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer. Arch Gynecol Obstet. 1997;259:147
  42. Schmidbauer J, Kratzik C, Klingler HC, Remzi M, Lackner J, Marberger M. Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease—improvement of renal function and quality of life. Eur Urol. 2006;50:1073
  43. Gasparini M, Carroll P, Stoller M. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology. 1991;38:408
  44. Chitale SV, Scott-Barrett S, Ho ET, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol. 2002;57:1118
  45. Aravantinos E, Karatzas A, Gravas S, Tzortzis V, Melekos M. Feasibility of percutaneous nephrolithotomy under assisted local anaesthesia: a prospective study on selected patients with upper urinary tract obstruction. Eur Urol. 2007;51:224

 See Editorial on page 435.

 Editor's Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 790 and 791.

PII: S0022-5347(08)00937-3

doi: 10.1016/j.juro.2008.04.008

The Journal of Urology
Volume 180, Issue 2 , Pages 444-450 , August 2008

Article Tools

* Image Usage & Resolution